You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Sacubitril and valsartan sodium hydrate drug combination

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Heart Failure, Systolic Trial in Karachi (Sacubitril/valsartan)

Completed
  • Heart Failure, Systolic
  • Karachi, Sindh, Pakistan
    National Institute of Cardiovascular Diseases
May 20, 2022

Hypertrophic Cardiomyopathy Trial in Worldwide (Lifestyle, Sacubitril/Valsartan)

Completed
  • Hypertrophic Cardiomyopathy
  • Regensburg, Germany
  • +4 more
Nov 23, 2022

Aortic Valve Insufficiency Trial in Seoul (Sacubitril-valsartan, Amlodipine-losartan)

Recruiting
  • Aortic Valve Insufficiency
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jan 27, 2022

Heart Failure With Reduced Ejection Fraction Trial in Leipzig, Kaiserslautern (Sacubitril-Valsartan)

Active, not recruiting
  • Heart Failure With Reduced Ejection Fraction
  • Leipzig, Saxony, Germany
  • +1 more
Dec 28, 2021

Heart Failure Trial (Placebo, XXB750 Low dose, XXB750 Medium Dose)

Not yet recruiting
  • Heart Failure
  • Placebo
  • +4 more
  • (no location specified)
Nov 24, 2023

Cardio-Renal Syndrome Trial in Qingdao (Roxadustat;Sacubitril Valsartan Sodium Tablets;, EPO; ACEI / ARB)

Recruiting
  • Cardio-Renal Syndrome
  • Roxadustat;Sacubitril Valsartan Sodium Tablets;
  • EPO; ACEI / ARB
  • Qingdao, Shangdong, China
    Department of Nephrology, Affiliated Hospital of Qingdao Univers
Sep 13, 2021

Myocardial Infarction, Hypertension Trial in Qingdao (Sacubitril/Valsartan 49/51mg/Tab, Valsartan 80mg/Tab)

Not yet recruiting
  • Myocardial Infarction
  • Hypertension
  • Sacubitril/Valsartan 49/51mg/Tab
  • Valsartan 80mg/Tab
  • Qingdao, Shandong, China
    Mengmei Li
Sep 18, 2021

Heart Failure Trial in Zagreb, Rotterdam (Sacubitril-Valsartan, Standard of care)

Recruiting
  • Heart Failure
  • Zagreb, Croatia
  • +2 more
Jan 17, 2022

Heart Failure Trial in Turku (sacubitril/valsatran, valsartan, to valsartan)

Recruiting
  • Heart Failure
  • Turku, Finland
    Novartis Investigative Site
Dec 2, 2021

Sacubitril/Valsartan in Improving Provider Performance in

Completed
  • Heart Failure
  • East Hanover, New Jersey
    Novartis Pharmaceuticals
Dec 15, 2021

Diabetes, Cardiovascular Diseases, Insulin Sensitivity/Resistance Trial in Birmingham (drug, other, dietary supplement)

Recruiting
  • Diabetes Mellitus
  • +6 more
  • Sacubitril, Valsartan 97-103 mg Oral Tablet
  • +4 more
  • Birmingham, Alabama
    University of Alabama at Birmingham
Aug 15, 2022

Cardiovascular Diseases, Heart Failure With Reduced Ejection Fraction Trial in Ostrava (Nebivolol, Valsartan and Sacubitril,

Not yet recruiting
  • Cardiovascular Diseases
  • Heart Failure With Reduced Ejection Fraction
  • Ostrava, Czech Republic, Czechia
    University Hospital Ostrava
Sep 6, 2023

STEMI Trial in Chengdu (Sacubitril-Valsartan, Enalapril, Valsartan)

Not yet recruiting
  • STEMI
  • Chengdu, Sichuan, China
    West China Hospital
Sep 23, 2021

Heart Failure With Preserved Ejection Fraction, Chronic Kidney Diseases Trial in Rochester (MANP, Sacubitril/Valsartan, Oral

Enrolling by invitation
  • Heart Failure With Preserved Ejection Fraction
  • Chronic Kidney Diseases
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Dec 22, 2022

Hypertension, Left Ventricular Hypertrophy Trial in Shanghai (sacubitril/valsartan, Amlodipine)

Recruiting
  • Hypertension
  • Left Ventricular Hypertrophy
  • Shanghai, China
    Shanghai Institite of Hypertension, Ruijin Hospital, Shanghai Ji
Dec 7, 2021

Heart Failure, Systolic Trial in Seoul (Sacubitril-Valsartan, Valsartan)

Recruiting
  • Heart Failure, Systolic
  • Seoul, Korea, Republic of
    Samsung Medical Center
Aug 17, 2021

Heart Failure Trial in Cairo (myocardial function after surgery)

Recruiting
  • Heart Failure
  • myocardial function after surgery
  • Cairo, Egypt
  • +1 more
Oct 13, 2023

Heart Failure With Reduced Ejection Fraction Patients Treated

Completed
  • Heart Failure
  • Trieste, Italy
    Novartis Investigative Site
Nov 7, 2022

Sodium-glucose Cotransporter 2 Inhibitors+Sacubitril/Valsartan

Recruiting
  • Heart Failure
  • +2 more
  • SGLT2 inhibitor
  • Roma, RM, Italy
    Fondazione Policlinico Universitario A. Gemelli IRCSS
Jun 28, 2023

Pulmonary Hypertension Trial in Badalona (Sacubitril / Valsartan Oral Tablet [Entresto])

Completed
  • Pulmonary Hypertension
  • Sacubitril / Valsartan Oral Tablet [Entresto]
  • Badalona, Barcelona, Spain
    Germans Trias i Pujol University Hospital
Sep 23, 2021

Chronic Heart Failure, Sleep Apnea Syndrome Trial in France (SACUBITRIL - VALSARTAN (formerly LCZ696, ENTRESTO®))

Completed
  • Chronic Heart Failure
  • Sleep Apnea Syndrome
  • SACUBITRIL - VALSARTAN (formerly LCZ696, ENTRESTO®)
  • Bordeaux, Pessac, France
  • +5 more
Jun 10, 2021

Heart Failure, Reduced Ejection Fraction Trial in United States (sacubitril/valsartan (LCZ696), enalapril, matching

Completed
Has Results
  • Heart Failure, Reduced Ejection Fraction
  • sacubitril/valsartan (LCZ696)
  • +3 more
  • Fort Payne, Alabama
  • +22 more
Oct 6, 2021

Hypertrophic Cardiomyopathy Trial in Newcastle (Sacubitril/Valsartan, Lifestyle)

Completed
  • Hypertrophic Cardiomyopathy
  • Newcastle, United Kingdom
    Newcastle NHS
May 4, 2022

Hypotension, Heart Failure Trial in Taipei (Dapagliflozin, Sacubitril-Valsartan, Beta blocker)

Completed
  • Hypotension
  • Heart Failure
  • Taipei, Taiwan
    Cheng Hsin General Hospital
Jul 27, 2021

Hypertensive Heart Disease Trial in Singapore (Entresto, Valsartan)

Recruiting
  • Hypertensive Heart Disease
  • Singapore, Singapore
    National Heart Centre Singapore
Apr 19, 2022